The promise offered by cell therapies is currently tempered by the many challenges associated with developing them. Through all the exciting advances and disappointing setbacks, it has become clear that collaboration is the key to success. No single organization has the complete solution to bringing these transformative therapies to market on their own. Regardless of size or focus, many organizations lack one or more of the critical components required to reach the clinic, whether it’s the infrastructure or expertise to conduct preclinical studies, manufacture to GMP standards or file regulatory submissions.
This collection of articles focuses on exciting developments in the field of cell therapy and many important considerations that can help you accelerate and achieve your cell therapy program goals.